Table 2.
A partial list of mechanisms implicated in acquired resistance to EGFR TKI
Secondary Mutations | Activation of alternate pathways | Other pathways |
---|---|---|
EGFR T790M (24, 25) | HER2 amplification (58) | Activation of PD-1 (30) |
EGFR D761Y (39) | MET amplification (26, 27) | Epithelial to mesenchymal transition (29, 33, 59) |
EGFR T854A (40) | mTORC1 (60) | Small Cell Transformation (61, 62) |
BRAF V600E (63) | AXL (64) | |
NRAS mutation (65) | IGF1-R (66, 67) | |
FGFR activation (68, 69) |